NovoCure Overview
NovoCure Target Price
Analysts' average 12-month price target for NovoCure is $38.
Get informed when a big investor buys or sells
+ FollowShare Price
$17.94
Average Target Price
$37.50
109% upside
109% upside4 analysts in the last 4 months
High: $52 | Low: $20
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-07-24 | Wedbush | $20 | 11.5% upside |  |
| 2026-07-24 | H.C. WainwrightEmily Bodnar | $32 | 78.4% upside | |
| 2026-07-23 | H.C. Wainwright | $52 | 189.9% upside | |
| 2026-06-18 | H.C. WainwrightEmily Bodnar | $46 | 156.4% upside | |
| 2026-02-12 | H.C. Wainwright | $47 | 162% upside | |
| 2026-01-13 | H.C. Wainwright | $39 | 117.4% upside | |
| 2026-01-05 | Evercore ISI | $20 | 11.5% upside | |
| 2025-10-30 | H.C. Wainwright | $42 | 134.1% upside | |
| 2025-07-24 | Wells FargoLarry Biegelsen | $14.5 |  19.2% downside | |
| 2024-12-02 | Evercore ISIVijay Kumar | $30 | 67.2% upside | |
| 2024-10-16 | H.C. WainwrightEmily Bodnar | $30 | 67.2% upside | |
| 2024-07-26 | H.C. WainwrightEmily Bodnar | $24 | 33.8% upside | |
| 2024-05-03 | H.C. WainwrightEmily Bodnar | $22 | 22.6% upside | |
| 2024-05-02 | Evercore ISIVijay Kumar | $14.5 | 19.2% downside | |
| 2024-04-10 | Piper SandlerJason Bednar | $28 | 56.1% upside | |
| 2024-04-03 | Wells FargoLarry Biegelsen | $42 | 134.1% upside | |
| 2024-03-27 | H.C. Wainwright | $24 | 33.8% upside | |
| 2023-01-06 | J.P. Morgan | $99 | 451.8% upside | |
| 2023-01-06 | Wells Fargo | $107 | 496.4% upside | |
| 2023-01-05 | H.C. WainwrightEmily Bodnar | $140 | 680.4% upside | |
| 2022-11-29 | Wells Fargo | $89 | 396.1% upside | |
| 2022-05-16 | H.C. WainwrightEmily Bodnar | $115 | 541% upside | |
| 2022-02-08 | Loop Capital MarketsJason Wittes | $200 | 1014.8% upside | |